[ Price : $8.95]
House Select Subcommittee on the Coronavirus Pandemic Republican leaders ask FDA for communications and interviews relating to pot...[ Price : $8.95]
Four stakeholders provide additional information to the U.S. Patent and Trademark Office about its collaboration with FDA.[ Price : $8.95]
FDAers in CDER and the Oncology Center of Excellence discuss the use of minimal residual disease (MRD) data in hematologic clinica...[ Price : $8.95]
Servier says a Phase 3 clinical trial assessing glioma drug vorasidenib met its primary and secondary endpoints.[ Price : $8.95]
A former Becton Dickinson medical director petitions FDA to scrutinize the companys 2017 510(k) clearance for the GalaForm 3D due...[ Price : $8.95]
FDA announces a 5/2 Webcast entitled Navigating the First ICH Generic Drug Draft Guideline M13A Bioequivalence for Immediate-Rele...[ Price : $8.95]
Still evolving under the same leadership, Dickinsons FDA Webview asks subscribers to help guide our further development and improv...[ Price : $8.95]
FDA clears a PeekMed 510(k) for its Web-based artificial intelligence automated planning solution for use in orthopedic surgery.